{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T20:15:40Z","timestamp":1769717740244,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s10067-025-07786-1","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T01:09:58Z","timestamp":1763082598000},"page":"531-540","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Etiologic spectrum and early mortality predictors in extreme hyperferritinemia: insights from rheumatology and hematology clinics"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2403-4675","authenticated-orcid":false,"given":"Mesut","family":"Ajder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6543-3905","authenticated-orcid":false,"given":"D\u00f6nd\u00fc \u00dcsk\u00fcdar","family":"Cansu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3251-1043","authenticated-orcid":false,"given":"Ertu\u011frul","family":"\u00c7olak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4434-4580","authenticated-orcid":false,"given":"Hava \u00dcsk\u00fcdar","family":"Teke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2679-0699","authenticated-orcid":false,"given":"Cengiz","family":"Korkmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"issue":"3","key":"7786_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0005-2728(96)00022-9","volume":"1275","author":"PM Harrison","year":"1996","unstructured":"Harrison PM, Arosio P (1996) The ferritins: molecular properties, iron storage function and cellular regulation. Biochimica et Biophysica Acta (BBA) 1275(3):161\u2013203. https:\/\/doi.org\/10.1016\/0005-2728(96)00022-9","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"1","key":"7786_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4024\/n03th12a.ntp.08.01","volume":"8","author":"EC Theil","year":"2012","unstructured":"Theil EC (2012) Ferritin protein nanocages-the story. Nanotechnology perceptions 8(1):7\u201316. https:\/\/doi.org\/10.4024\/n03th12a.ntp.08.01","journal-title":"Nanotechnology perceptions"},{"issue":"9","key":"7786_CR3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/intimm\/dxx031","volume":"29","author":"KF Kernan","year":"2017","unstructured":"Kernan KF, Carcillo JA (2017) Hyperferritinemia and inflammation. Int Immunol 29(9):401\u2013409. https:\/\/doi.org\/10.1093\/intimm\/dxx031","journal-title":"Int Immunol"},{"issue":"1","key":"7786_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-020-01102-8","volume":"19","author":"A Sciacqua","year":"2020","unstructured":"Sciacqua A, Ventura E, Tripepi G, Cassano V, D\u2019Arrigo G, Roumeliotis S, Maio R, Miceli S, Perticone M, Andreozzi F, Sesti G, Perticone F (2020) Ferritin modifies the relationship between inflammation and arterial stiffness in hypertensive patients with different glucose tolerance. Cardiovasc Diabetol 19(1):123. https:\/\/doi.org\/10.1186\/s12933-020-01102-8","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"7786_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0308-2261(21)00338-6","volume":"11","author":"M Worwood","year":"1982","unstructured":"Worwood M (1982) Ferritin in human tissues and serum. Clin Haematol 11(2):275\u2013307","journal-title":"Clin Haematol"},{"issue":"2","key":"7786_CR6","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jhep.2011.02.010","volume":"55","author":"PC Adams","year":"2011","unstructured":"Adams PC, Barton JC (2011) A diagnostic approach to hyperferritinemia with a non-elevated transferrin saturation. J Hepatol 55(2):453\u2013458. https:\/\/doi.org\/10.1016\/j.jhep.2011.02.010","journal-title":"J Hepatol"},{"key":"7786_CR7","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.2147\/DMSO.S271050","volume":"13","author":"RJ Tofano","year":"2020","unstructured":"Tofano RJ, Pescinni-Salzedas LM, Chagas EFB, Detregiachi CRP, Guiguer EL, Araujo AC, Bechara MD, Rubira CJ, Barbalho SM (2020) Association of metabolic syndrome and hyperferritinemia in patients at cardiovascular risk. Diabetes Metab Syndr Obes Targets Ther 13:3239\u20133248. https:\/\/doi.org\/10.2147\/DMSO.S271050","journal-title":"Diabetes Metab Syndr Obes Targets Ther"},{"issue":"10","key":"7786_CR8","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1080\/10245332.2018.1488569","volume":"23","author":"H Senjo","year":"2018","unstructured":"Senjo H, Higuchi T, Okada S, Takahashi O (2018) Hyperferritinemia: causes and significance in a general hospital. Hematology (Amsterdam, Netherlands) 23(10):817\u2013822. https:\/\/doi.org\/10.1080\/10245332.2018.1488569","journal-title":"Hematology (Amsterdam, Netherlands)"},{"issue":"4","key":"7786_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.4081\/reumatismo.2019.1221","volume":"71","author":"N Belfeki","year":"2020","unstructured":"Belfeki N, Strazzulla A, Picque M, Diamantis S (2020) Extreme hyperferritinemia: etiological spectrum and impact on prognosis. Reumatismo 71(4):199\u2013202. https:\/\/doi.org\/10.4081\/reumatismo.2019.1221","journal-title":"Reumatismo"},{"issue":"5","key":"7786_CR10","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1093\/ajcp\/aqw053","volume":"145","author":"K Sackett","year":"2016","unstructured":"Sackett K, Cunderlik M, Sahni N, Killeen AA, Olson AP (2016) Extreme hyperferritinemia: causes and \u0131mpact on diagnostic reasoning. Am J Clin Pathol 145(5):646\u2013650. https:\/\/doi.org\/10.1093\/ajcp\/aqw053","journal-title":"Am J Clin Pathol"},{"key":"7786_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13215","author":"I Thorne","year":"2018","unstructured":"Thorne I, Stroud J, Penn H (2018) A retrospective series of conditions and mortality associated with extreme hyperferritinaemia in adults. Int J Clin Pract. https:\/\/doi.org\/10.1111\/ijcp.13215","journal-title":"Int J Clin Pract"},{"issue":"5","key":"7786_CR12","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1136\/jclinpath-2012-201090","volume":"66","author":"MA Crook","year":"2013","unstructured":"Crook MA, Walker PL (2013) Extreme hyperferritinaemia; clinical causes. J Clin Pathol 66(5):438\u2013440. https:\/\/doi.org\/10.1136\/jclinpath-2012-201090","journal-title":"J Clin Pathol"},{"issue":"18","key":"7786_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11185438","volume":"11","author":"M Fauter","year":"2022","unstructured":"Fauter M, Mainbourg S, El Jammal T, Guerber A, Zaepfel S, Henry T, Gerfaud-Valentin M, S\u00e8ve P, Jamilloux Y (2022) Extreme hyperferritinemia: causes and prognosis. J Clin Med 11(18):5438. https:\/\/doi.org\/10.3390\/jcm11185438","journal-title":"J Clin Med"},{"issue":"8","key":"7786_CR14","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/imj.12768","volume":"45","author":"AJ Wormsbecker","year":"2015","unstructured":"Wormsbecker AJ, Sweet DD, Mann SL, Wang SY, Pudek MR, Chen LY (2015) Conditions associated with extreme hyperferritinaemia (>3000 \u03bcg\/L) in adults. Intern Med J 45(8):828\u2013833. https:\/\/doi.org\/10.1111\/imj.12768","journal-title":"Intern Med J"},{"issue":"9","key":"7786_CR15","doi-asserted-by":"publisher","first-page":"574","DOI":"10.14423\/SMJ.0000000000000339","volume":"108","author":"T Beer","year":"2015","unstructured":"Beer T, Vadakara J (2015) Etiologies and short-term mortality in patients with ultraelevated serum ferritin. South Med J 108(9):574\u2013578. https:\/\/doi.org\/10.14423\/SMJ.0000000000000339","journal-title":"South Med J"},{"issue":"5","key":"7786_CR16","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1007\/s11845-024-03698-2","volume":"193","author":"AT G\u00fcven","year":"2024","unstructured":"G\u00fcven AT, Hocan\u0131n N, Ambark\u00fct\u00fcko\u011flu AE (2024) Predictors of mortality, mortality rates, and clinical characteristics of adult patients with extreme hyperferritinemia. Irish Journal of Medical Science (1971 -) 193(5):2325\u20132331. https:\/\/doi.org\/10.1007\/s11845-024-03698-2","journal-title":"Irish Journal of Medical Science (1971 -)"},{"issue":"9","key":"7786_CR17","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1007\/s00296-021-04935-y","volume":"41","author":"D \u00dcsk\u00fcdar Cansu","year":"2021","unstructured":"\u00dcsk\u00fcdar Cansu D, \u00dcsk\u00fcdar Teke H, Cansu GB, Korkmaz C (2021) Evaluation of hyperferritinemia causes in rheumatology practice: a retrospective, single-center experience. Rheumatol Int 41(9):1617\u20131624. https:\/\/doi.org\/10.1007\/s00296-021-04935-y","journal-title":"Rheumatol Int"},{"issue":"7","key":"7786_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0235326","volume":"15","author":"P Di Benedetto","year":"2020","unstructured":"Di Benedetto P, Cipriani P, Iacono D, Pantano I, Caso F, Emmi G, Grembiale RD, Cantatore FP, Atzeni F, Perosa F, Scarpa R, Guggino G, Ciccia F, Giacomelli R, Ruscitti P (2020) Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still\u2019s disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort. PLoS One 15(7):e0235326. https:\/\/doi.org\/10.1371\/journal.pone.0235326","journal-title":"PLoS One"},{"issue":"12","key":"7786_CR19","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1093\/ndt\/gfy190","volume":"33","author":"A Karaboyas","year":"2018","unstructured":"Karaboyas A, Morgenstern H, Pisoni RL, Zee J, Vanholder R, Jacobson SH, Inaba M, Loram LC, Port FK, Robinson BM (2018) Association between serum ferritin and mortality: findings from the USA, Japan and European Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant 33(12):2234\u20132244. https:\/\/doi.org\/10.1093\/ndt\/gfy190","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"7786_CR20","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/RHU.0b013e31829ce01f","volume":"19","author":"C Moore Jr","year":"2013","unstructured":"Moore C Jr, Ormseth M, Fuchs H (2013) Causes and significance of markedly elevated serum ferritin levels in an academic medical center. J Clin Rheumatol 19(6):324\u2013328. https:\/\/doi.org\/10.1097\/RHU.0b013e31829ce01f","journal-title":"J Clin Rheumatol"},{"issue":"2","key":"7786_CR21","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G (2007) HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48(2):124\u2013131. https:\/\/doi.org\/10.1002\/pbc.21039","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"7786_CR22","first-page":"424","volume":"19","author":"M Yamaguchi","year":"1992","unstructured":"Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, Kashiwazaki S, Tanimoto K, Matsumoto Y, Ota T (1992) Preliminary criteria for classification of adult Still\u2019s disease. J Rheumatol 19(3):424\u2013430","journal-title":"J Rheumatol"},{"issue":"10","key":"7786_CR23","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1182\/blood-2014-10-602607","volume":"125","author":"AM Schram","year":"2015","unstructured":"Schram AM, Campigotto F, Mullally A, Fogerty A, Massarotti E, Neuberg D, Berliner N (2015) Marked hyperferritinemia does not predict for HLH in the adult population. Blood 125(10):1548\u20131552. https:\/\/doi.org\/10.1182\/blood-2014-10-602607","journal-title":"Blood"},{"issue":"9","key":"7786_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10092008","volume":"10","author":"M Sandnes","year":"2021","unstructured":"Sandnes M, Ulvik RJ, Vorland M, Reikvam H (2021) Hyperferritinemia-a clinical overview. J Clin Med 10(9):2008. https:\/\/doi.org\/10.3390\/jcm10092008","journal-title":"J Clin Med"},{"issue":"4","key":"7786_CR25","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/CCM.0000000000004131","volume":"48","author":"G Lachmann","year":"2020","unstructured":"Lachmann G, Knaak C, Vorderw\u00fclbecke G, La Ros\u00e9e P, Balzer F, Schenk T, Schuster FS, Nyvlt P, Janka G, Brunkhorst FM, Keh D, Spies C (2020) Hyperferritinemia in critically ill patients. Crit Care Med 48(4):459\u2013465. https:\/\/doi.org\/10.1097\/CCM.0000000000004131","journal-title":"Crit Care Med"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07786-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07786-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07786-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T09:41:16Z","timestamp":1769679676000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07786-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["7786"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07786-1","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of Eskisehir Osmangazi University with decision number of 27, decision dated April 11, 2023. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. For this type of retrospective study, formal written informed consent is not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Disclosures"}}]}}